Propanc Biopharma, Inc. SEC filings PPCB
Propanc Biopharma, Inc. has 438 filings in SEC EDGAR's recent list, going back to Jun 23, 2011. Its latest annual report, Form 10-K, was filed on Sep 25, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 14, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (listing notice). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 19, 2025 | — |
| 4 | Insider transaction | Aug 23, 2023 | Jul 5, 2023 |
| SC 13G | Ownership over 5% (passive) | Sep 8, 2021 | — |
| 4 | Insider transaction | Aug 20, 2021 | Aug 17, 2021 |
| 4 | Insider transaction | Aug 20, 2021 | Aug 17, 2021 |
| 3 | Initial insider ownership | Aug 20, 2021 | Aug 17, 2021 |
| SC 13G | Ownership over 5% (passive) | Jul 7, 2020 | — |
| SC 13G | Ownership over 5% (passive) | Jul 7, 2020 | — |
| 3 | Initial insider ownership | Jun 28, 2019 | Jun 24, 2019 |
| 4 | Insider transaction | May 22, 2019 | May 14, 2019 |
| 4 | Insider transaction | May 17, 2019 | May 14, 2019 |
| SC 13G | Ownership over 5% (passive) | Sep 14, 2018 | — |
| 4 | Insider transaction | Sep 27, 2016 | Feb 4, 2015 |
| 4 | Insider transaction | Sep 27, 2016 | Feb 4, 2015 |
| 4 | Insider transaction | Jan 13, 2015 | Sep 4, 2012 |
| SC 13D | Ownership over 5% (active) | Jan 2, 2015 | — |
| SC 13G | Ownership over 5% (passive) | Aug 2, 2013 | — |
| 4 | Insider transaction | Aug 24, 2012 | Aug 23, 2012 |
| 3/A | Primary document | Aug 22, 2012 | Jul 16, 2012 |
| 3 | Initial insider ownership | Aug 6, 2012 | Jul 16, 2012 |
| 3 | Initial insider ownership | Jul 26, 2012 | Dec 16, 2011 |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PPCB (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Camberwell, Victoria, Australia
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1517681
- Former names
- Propanc Health Group Corp (until Apr 5, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.